Copyright Reports & Markets. All rights reserved.

Global Biotherapeutics Cell Line Development Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Transfection & Selection
      • 1.4.3 Single Cell Cloning
    • 1.5 Market by Application
      • 1.5.1 Global Biotherapeutics Cell Line Development Market Share by Application (2014-2025)
      • 1.5.2 In-house
      • 1.5.3 Outsource
      • 1.5.4 Hybrid
      • 1.5.5 Do-It-Yourself (DIY)
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Biotherapeutics Cell Line Development Market Size
    • 2.2 Biotherapeutics Cell Line Development Growth Trends by Regions
      • 2.2.1 Biotherapeutics Cell Line Development Market Size by Regions (2014-2025)
      • 2.2.2 Biotherapeutics Cell Line Development Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Biotherapeutics Cell Line Development Market Size by Manufacturers
      • 3.1.1 Global Biotherapeutics Cell Line Development Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Biotherapeutics Cell Line Development Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Biotherapeutics Cell Line Development Market Concentration Ratio (CR5 and HHI)
    • 3.2 Biotherapeutics Cell Line Development Key Players Head office and Area Served
    • 3.3 Key Players Biotherapeutics Cell Line Development Product/Solution/Service
    • 3.4 Date of Enter into Biotherapeutics Cell Line Development Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Biotherapeutics Cell Line Development Market Size by Type (2014-2019)
    • 4.2 Global Biotherapeutics Cell Line Development Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Biotherapeutics Cell Line Development Market Size (2014-2019)
    • 5.2 Biotherapeutics Cell Line Development Key Players in United States
    • 5.3 United States Biotherapeutics Cell Line Development Market Size by Type
    • 5.4 United States Biotherapeutics Cell Line Development Market Size by Application

    6 Europe

    • 6.1 Europe Biotherapeutics Cell Line Development Market Size (2014-2019)
    • 6.2 Biotherapeutics Cell Line Development Key Players in Europe
    • 6.3 Europe Biotherapeutics Cell Line Development Market Size by Type
    • 6.4 Europe Biotherapeutics Cell Line Development Market Size by Application

    7 China

    • 7.1 China Biotherapeutics Cell Line Development Market Size (2014-2019)
    • 7.2 Biotherapeutics Cell Line Development Key Players in China
    • 7.3 China Biotherapeutics Cell Line Development Market Size by Type
    • 7.4 China Biotherapeutics Cell Line Development Market Size by Application

    8 Japan

    • 8.1 Japan Biotherapeutics Cell Line Development Market Size (2014-2019)
    • 8.2 Biotherapeutics Cell Line Development Key Players in Japan
    • 8.3 Japan Biotherapeutics Cell Line Development Market Size by Type
    • 8.4 Japan Biotherapeutics Cell Line Development Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Biotherapeutics Cell Line Development Market Size (2014-2019)
    • 9.2 Biotherapeutics Cell Line Development Key Players in Southeast Asia
    • 9.3 Southeast Asia Biotherapeutics Cell Line Development Market Size by Type
    • 9.4 Southeast Asia Biotherapeutics Cell Line Development Market Size by Application

    10 India

    • 10.1 India Biotherapeutics Cell Line Development Market Size (2014-2019)
    • 10.2 Biotherapeutics Cell Line Development Key Players in India
    • 10.3 India Biotherapeutics Cell Line Development Market Size by Type
    • 10.4 India Biotherapeutics Cell Line Development Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Biotherapeutics Cell Line Development Market Size (2014-2019)
    • 11.2 Biotherapeutics Cell Line Development Key Players in Central & South America
    • 11.3 Central & South America Biotherapeutics Cell Line Development Market Size by Type
    • 11.4 Central & South America Biotherapeutics Cell Line Development Market Size by Application

    12 International Players Profiles

    • 12.1 Becton Dickinson & Company
      • 12.1.1 Becton Dickinson & Company Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Biotherapeutics Cell Line Development Introduction
      • 12.1.4 Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2014-2019)
      • 12.1.5 Becton Dickinson & Company Recent Development
    • 12.2 Beckman Coulter
      • 12.2.1 Beckman Coulter Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Biotherapeutics Cell Line Development Introduction
      • 12.2.4 Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2014-2019)
      • 12.2.5 Beckman Coulter Recent Development
    • 12.3 Boehringer Ingelheim Group
      • 12.3.1 Boehringer Ingelheim Group Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Biotherapeutics Cell Line Development Introduction
      • 12.3.4 Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2014-2019)
      • 12.3.5 Boehringer Ingelheim Group Recent Development
    • 12.4 Catalent Inc.
      • 12.4.1 Catalent Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Biotherapeutics Cell Line Development Introduction
      • 12.4.4 Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2014-2019)
      • 12.4.5 Catalent Inc. Recent Development
    • 12.5 CMC Biologics A/S
      • 12.5.1 CMC Biologics A/S Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Biotherapeutics Cell Line Development Introduction
      • 12.5.4 CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2014-2019)
      • 12.5.5 CMC Biologics A/S Recent Development
    • 12.6 Lonza Group Ltd.
      • 12.6.1 Lonza Group Ltd. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Biotherapeutics Cell Line Development Introduction
      • 12.6.4 Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2014-2019)
      • 12.6.5 Lonza Group Ltd. Recent Development
    • 12.7 EMD Millipore
      • 12.7.1 EMD Millipore Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Biotherapeutics Cell Line Development Introduction
      • 12.7.4 EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2014-2019)
      • 12.7.5 EMD Millipore Recent Development
    • 12.8 Partec (Sysmex Corporation)
      • 12.8.1 Partec (Sysmex Corporation) Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Biotherapeutics Cell Line Development Introduction
      • 12.8.4 Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2014-2019)
      • 12.8.5 Partec (Sysmex Corporation) Recent Development
    • 12.9 ProBioGen AG
      • 12.9.1 ProBioGen AG Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Biotherapeutics Cell Line Development Introduction
      • 12.9.4 ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2014-2019)
      • 12.9.5 ProBioGen AG Recent Development
    • 12.10 Selexis SA
      • 12.10.1 Selexis SA Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Biotherapeutics Cell Line Development Introduction
      • 12.10.4 Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2014-2019)
      • 12.10.5 Selexis SA Recent Development
    • 12.11 Sigma-Aldrich Co. LLC.
    • 12.12 Sony Biotechnology Inc.
    • 12.13 Thermo Fisher Scientific Inc.

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Biotherapeutics Cell Line Development market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Biotherapeutics Cell Line Development status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biotherapeutics Cell Line Development development in United States, Europe and China.

      The key players covered in this study
      Becton Dickinson & Company
      Beckman Coulter
      Boehringer Ingelheim Group
      Catalent Inc.
      CMC Biologics A/S
      Lonza Group Ltd.
      EMD Millipore
      Partec (Sysmex Corporation)
      ProBioGen AG
      Selexis SA
      Sigma-Aldrich Co. LLC.
      Sony Biotechnology Inc.
      Thermo Fisher Scientific Inc.

      Market segment by Type, the product can be split into
      Transfection & Selection
      Single Cell Cloning

      Market segment by Application, split into
      In-house
      Outsource
      Hybrid
      Do-It-Yourself (DIY)

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Biotherapeutics Cell Line Development status, future forecast, growth opportunity, key market and key players.
      To present the Biotherapeutics Cell Line Development development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Biotherapeutics Cell Line Development are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now